Bressler Adam M, Kaye Keith S, LiPuma John J, Alexander Barbara D, Moore Christopher M, Reller L Barth, Woods Christopher W
Infectious Disease Specialists of Atlanta and Clinical Microbiology Laboratory, Dekalb Medical Center, Atlanta, GA, USA.
Infect Control Hosp Epidemiol. 2007 Aug;28(8):951-8. doi: 10.1086/519177. Epub 2007 Jun 29.
The Burkholderia cepacia complex is associated with colonization or disease in patients with cystic fibrosis (CF). For patients without CF, this complex is poorly understood apart from its presence in occasional point source outbreaks.
To investigate risk factors for B. cepacia bacteremia in hospitalized, intensive care unit patients without CF.
We identified patients with 1 or more blood cultures positive for B. cepacia between May 1, 1996, and March 31, 2002, excluding those with CF. Control patients were matched to case patients by ward, duration of hospitalization, and onset date of bacteremia. Matched analyses were used to identify risk factors for B. cepacia bacteremia.
We enrolled 40 patients with B. cepacia bacteremia into the study. No environmental or other point source for B. cepacia complex was identified, although horizontal spread was suspected. Implementation of contact precautions was effective in decreasing the incidence of B. cepacia bacteremia. We selected 119 matched controls. Age, sex, and race were similar between cases and controls. In multivariable analysis, renal failure that required dialysis, recent abdominal surgery, 2 or more bronchoscopic procedures before detection of B. cepacia bacteremia, tracheostomy, and presence of a central line before detection of B. cepacia bacteremia were independently associated with development of B. cepacia bacteremia, whereas presence of a percutaneous feeding tube was associated with a lower risk of disease.
B. cepacia complex is an important emerging group of nosocomial pathogens in patients with and patients without CF. Nosocomial spread is likely facilitated by cross-transmission, frequent pulmonary procedures, and central venous access. Infection control measures appear useful for limiting the spread of virulent, transmissible clones of B. cepacia complex.
洋葱伯克霍尔德菌复合体与囊性纤维化(CF)患者的定植或疾病有关。对于非CF患者,除了在偶尔的点源暴发中出现外,对该复合体了解甚少。
调查非CF的住院重症监护病房患者发生洋葱伯克霍尔德菌血症的危险因素。
我们确定了1996年5月1日至2002年3月31日期间1例或更多血培养洋葱伯克霍尔德菌阳性的患者,排除CF患者。对照患者按病房、住院时间和菌血症发病日期与病例患者匹配。采用匹配分析确定洋葱伯克霍尔德菌血症的危险因素。
我们将40例洋葱伯克霍尔德菌血症患者纳入研究。尽管怀疑有水平传播,但未发现洋葱伯克霍尔德菌复合体的环境或其他点源。实施接触预防措施可有效降低洋葱伯克霍尔德菌血症的发生率。我们选择了119例匹配对照。病例组和对照组的年龄、性别和种族相似。在多变量分析中,需要透析的肾衰竭、近期腹部手术、在检测到洋葱伯克霍尔德菌血症之前进行2次或更多次支气管镜检查、气管切开术以及在检测到洋葱伯克霍尔德菌血症之前存在中心静脉导管与洋葱伯克霍尔德菌血症的发生独立相关,而经皮饲管的存在与疾病风险较低相关。
洋葱伯克霍尔德菌复合体是CF患者和非CF患者中重要的新兴医院病原体群体。交叉传播、频繁的肺部手术和中心静脉通路可能促进了医院内传播。感染控制措施似乎有助于限制洋葱伯克霍尔德菌复合体毒性强、可传播克隆的传播。